feed,title,long_url,short_url
Benzinga,"Biohaven's ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months",https://benzinga.com/general/biotech/22/09/29075549/biohavens-als-drug-fails-to-meet-study-endpoint-second-therapy-to-fail-trials-in-recent-months,https://bit.ly/3LRcK8A
